Nationwide cohort study on the risk of high‐grade cervical dysplasia and carcinoma after conservative treatment or hysterectomy for adenocarcinoma in situ
Mirte Schaafsma,Teska N. Schuurman,Pien Kootstra,Deli Issa,Ivo Hermans,Maaike C. G. Bleeker,Petra L. M. Zusterzeel,Ruud L. M. Bekkers,Albert G. Siebers,Constantijne H. Mom,Nienke E. van Trommel
DOI: https://doi.org/10.1002/ijc.35237
2024-11-05
International Journal of Cancer
Abstract:What's New? There are various strategies available for the treatment of cervical adenocarcinoma in situ (AIS). Which approach is the most effective for preventing progression to cervical carcinoma, however, remains uncertain. In this study, the authors compared outcomes of AIS patients treated with either large loop excision of the transformation zone (LLETZ), cold‐knife conization (CKC), or hysterectomy. Following radical LLETZ or radical CKC, cervical high‐grade dysplasia and local cervical cancer incidence were similar, while no malignancies developed after hysterectomy. The data indicate that conservative treatment with successful radical excision can be an effective long‐term treatment modality for AIS. Internationally, little consensus exists about the best treatment for cervical adenocarcinoma in situ (AIS). This study aimed to determine the incidence of recurrent high‐grade cervical dysplasia and development of local cervical cancer after treatment for AIS. This nationwide, retrospective cohort study included patients with AIS, who were treated by a large loop excision of the transformation zone (LLETZ), cold‐knife conization (CKC), or hysterectomy between January 1, 1990 and December 31, 2021 in the Netherlands. Pathology reports were retrieved from the Dutch Nationwide Pathology Databank (Palga). Primary outcomes were the cumulative incidences of high‐grade cervical dysplasia (cervical intraepithelial neoplasia grade 2 or 3, and AIS) and local cervical cancer up to 20 years after primary treatment. In total, 4243 patients with AIS were included. The primary treatment was a LLETZ, CKC, or hysterectomy in 1593, 2118, and 532 patients, respectively. The incidence of recurrent high‐grade cervical dysplasia after LLETZ (10.5%; 95%CI: 8.6–12.3) was higher than after CKC (5.5%; 95%CI: 4.4–6.6, p
oncology